Jarislowsky, Fraser LTD Bristol Myers Squibb CO Transaction History

Jarislowsky, Fraser LTD

$14.9 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 27, 2024	SELL	$63.71 - $70.74 $105,440 - $117,074	-1,655 Reduced 32.29%	3,470 $221,000
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $105,440 - $117,074	-1,655 Reduced 32.29%	3,470 $221,000
Q1 2023 Sep 27, 2024	BUY	$65.71 - $74.53 $336,763 - $381,966	5,125 New	5,125 $355,000
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $44,682 - $50,680	-680 Reduced 11.71%	5,125 $355,000
Q4 2022 Sep 27, 2024	BUY	$68.48 - $81.09 $397,526 - $470,727	5,805 New	5,805 $417,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $8,217 - $9,730	-120 Reduced 2.03%	5,805 $417,000
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $18 - $11,218	-146 Reduced 2.4%	5,925 $421,000
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $41,563 - $48,453	-775 Reduced 11.32%	6,071 $378,000
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $53,490 - $58,250	-864 Reduced 11.21%	6,846 $457,000
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $907,902 - $1.02 Million	-15,300 Reduced 66.49%	7,710 $486,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $7,506 - $8,505	130 Added 0.57%	23,010 $1.43 Million
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $33,481 - $37,102	-583 Reduced 2.48%	22,880 $1.38 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $64,577 - $75,498	-1,178 Reduced 4.78%	23,463 $1.38 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $87,139 - $126,633	-1,878 Reduced 7.08%	24,641 $1.37 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $362,234 - $472,502	-7,361 Reduced 21.73%	26,519 $1.7 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $95,120 - $112,779	-2,224 Reduced 6.16%	33,880 $1.72 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $274,859 - $303,934	-6,160 Reduced 14.58%	36,104 $1.64 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $27.9 Million - $33.3 Million	-618,529 Reduced 93.6%	42,264 $2.02 Million
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $1.46 Million - $1.89 Million	-29,846 Reduced 4.32%	660,793 $34.3 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $19.2 Million - $21.7 Million	-348,374 Reduced 33.53%	690,639 $34.9 Million
Q2 2018 Aug 10, 2018	BUY	$50.53 - $62.98 $12.2 Million - $15.2 Million	241,811 Added 30.33%	1,039,013 $57.5 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $3.37 Million - $3.88 Million	56,245 Added 7.59%	797,202 $0
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $12.6 Million - $13.7 Million	-210,247 Reduced 22.1%	740,957 $0
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $52.5 Million - $60.6 Million	951,204	951,204 $60.6 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.

Account